L Dorey
Factors influencing the potency of marbofloxacin for pig pneumonia pathogens Actinobacillus pleuropneumoniae and Pasteurella multocida
Dorey, L; Hobson, S; Lees, P
Authors
S Hobson
P Lees
Abstract
For the pig respiratory tract pathogens, Actinobacillus pleuropneumoniae and Pasteurella multocida, Minimum Inhibitory Concentration (MIC) of marbofloxacin was determined in recommended broths and pig serum at three inoculum strengths. MICs in both growth matrices increased progressively from low, through medium to high starting inoculum counts, 104, 106 and 108 CFU/mL, respectively. P. multocida MIC ratios for high:low inocula were 14:4:1 for broth and 28.2:1 for serum. Corresponding MIC ratios for A. pleuropneumoniae were lower, 4.1:1 (broth) and 9.2:1 (serum). MIC high:low ratios were therefore both growth matrix and bacterial species dependent. The effect of alterations to the chemical composition of broths and serum on MIC were also investigated. Neither adjusting broth or serum pH in six increments over the range 7.0 to 8.0 nor increasing calcium and magnesium concentrations of broth in seven incremental steps significantly affected MICs for either organism. In time-kill studies, the killing action of marbofloxacin had the characteristics of concentration dependency against both organisms in both growth matrices. It is concluded that MIC and time-kill data for marbofloxacin, generated in serum, might be preferable to broth data, for predicting dosages of marbofloxacin for clinical use.
Citation
Dorey, L., Hobson, S., & Lees, P. (2017). Factors influencing the potency of marbofloxacin for pig pneumonia pathogens Actinobacillus pleuropneumoniae and Pasteurella multocida. Research in Veterinary Science, 111, 93-98. https://doi.org/10.1016/j.rvsc.2016.11.011
Journal Article Type | Article |
---|---|
Acceptance Date | Nov 25, 2016 |
Publication Date | Apr 1, 2017 |
Deposit Date | Nov 29, 2016 |
Publicly Available Date | Nov 29, 2016 |
Journal | RESEARCH IN VETERINARY SCIENCE |
Print ISSN | 0034-5288 |
Publisher | Elsevier |
Peer Reviewed | Peer Reviewed |
Volume | 111 |
Pages | 93-98 |
DOI | https://doi.org/10.1016/j.rvsc.2016.11.011 |
Public URL | https://rvc-repository.worktribe.com/output/1392483 |
Files
10617.pdf
(980 Kb)
PDF
You might also like
Biased computation of Probability of Target Attainment for antimicrobial drugs
(2023)
Journal Article
Pharmacology, safety, efficacy and clinical uses of the COX‐2 inhibitor robenacoxib
(2022)
Journal Article
Levothyrox® new and old formulations: are they switchable for millions of patients?
(2019)
Journal Article
Downloadable Citations
About RVC Repository
Administrator e-mail: publicationsrepos@rvc.ac.uk
This application uses the following open-source libraries:
SheetJS Community Edition
Apache License Version 2.0 (http://www.apache.org/licenses/)
PDF.js
Apache License Version 2.0 (http://www.apache.org/licenses/)
Font Awesome
SIL OFL 1.1 (http://scripts.sil.org/OFL)
MIT License (http://opensource.org/licenses/mit-license.html)
CC BY 3.0 ( http://creativecommons.org/licenses/by/3.0/)
Powered by Worktribe © 2024
Advanced Search